SNSS Stock Price, News & Analysis

SNSS NASDAQ

Company Description

SNSS (NASDAQ: SNSS) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

SNSS stock has gained 478.3% over the past year.

This page provides a comprehensive overview of SNSS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+478.26%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

SNSS (SNSS) stock. Over the past 12 months, the stock has gained 478.3%.

Latest News

View All

February 24, 2021

—

Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement

private placement acquisition

February 16, 2021

+8.16%

Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma

February 11, 2021

+0.30%

Viracta Therapeutics to Participate in Upcoming Virtual Investor Conferences

conferences

December 7, 2020

+2.31%

Viracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDA

clinical trial fda approval

November 30, 2020

+24.00%

Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement

acquisition

November 16, 2020

-3.85%

Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

earnings

SNSS has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include private placement, acquisition, conferences, clinical trial, fda approval. View all SNSS news →

SEC Filings

View All

No SEC filings available for SNSS.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SNSS Company Profile & Sector Positioning

SNSS (SNSS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.